Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 9Thoracic 3Gynecologic 3Other neoplasm 1NET 1Lymphoid 1Gastrointestinal 1Endocrine 1

Conditions

Gastric Adenocarcinoma 1

Interventions

Cyclophosphamide 7fludarabine phosphate 6Peripheral Blood Stem Cell Transplantation 6Whole-Body Irradiation 5Tacrolimus 4Mycophenolic Acid 4Methotrexate 4Melphalan 4Busulfan 4Sulindac 3Paclitaxel 3Cyclosporine 3Cisplatin 3Capecitabine 3Biopsy 3Antilymphocyte Serum 3toripalimab 2sintilimab 2fludarabine 2Taxes 2Surveys and Questionnaires 2Specimen Handling 2Sirolimus 2Radiotherapy 2Patient Reported Outcome Measures 2Nivolumab 2Mesna 2Magnetic Resonance Spectroscopy 2Hyperthermic Intraperitoneal Chemotherapy 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × taxane × Other neoplasm × Clear all
NCT05753306 2026-04-08

Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study

Mayo Clinic

Phase 2 Recruiting
40 enrolled
GastrointestinalOther neoplasm

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡